TERESA KIM: Open Payments
NPI 1386078327 · CERRITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 32 payments from 15 companies in 2025. Trend: 2023 $1,791 · 2024 $1,481 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $288 |
| Novo Nordisk Inc | 3 | $170 |
| AstraZeneca Pharmaceuticals LP | 2 | $151 |
| ViiV Healthcare Company | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $120 |
| Kowa Pharmaceuticals America, Inc. | 1 | $118 |
| GlaxoSmithKline, LLC. | 4 | $107 |
| PFIZER INC. | 4 | $84 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
Products named: Kerendia, BREZTRI, Wegovy, APRETUDE, Vemlidy, ZORYVE, PREVNAR 20, SHINGRIX.
Industry payments across CA — which companies pay providers there.
